Compared to normal controls, the expression of PROS1 mRNA was significantly downregulated in ICC patient cancer tissues (p<0.05) but not in peripheral plasma (p>0.05). This evidence concerns the gene PROS1 and intrahepatic cholangiocarcinoma.